What We Do

Patients depend on pharmaceutical products and devices being what they’re supposed to be and doing what they’re supposed to do.  When they turn out to be counterfeit/unreliable, there can be dire results for women and their families.

WomanCare Global protects product integrity by closely monitoring all aspects of the manufacturing, packaging and distribution of products and requiring that suppliers meet certain standards.  Products produced for WomanCare Global are expected to comply with worldwide quality standards and regulatory requirements.

WomanCare Global distributes to over 110 countries and understands that a product portfolio mix including pregnancy management technologies is critical to women in the developing world.  We are dedicated to expanding the availability of reproductive technologies worldwide.

Sexual violence is a serious, present-day emergency affecting millions of women and girls.  One in five women worldwide will become a victim of rape or attempted rape in her lifetime.² In armed conflict, systematic rape is often used as a military tactic and women are raped repeatedly as a weapon of war .² 

WomanCare Global products are included in the UNFPA reproductive health kits (Minimum Initial Service Package Sub-Kit Eight) for use in crisis situations, and the humanitarian response organizations that purchase WomanCare Global products include the International Committee of the Red Cross and Médecins Sans Frontières.

Lack of access happens all too often in countries when a pharmacy or dispensary runs out of essential medicine. For women, supply shortages not only make family planning next to impossible, they endanger the entire family.

WomanCare Global has a disciplined channel of global distributors and professional detailers who are involved with product registration to end use. By effectively forecasting current demand, potential market growth and maintaining an appropriate inventory level for unforeseen anomalies, WomanCare Global promotes sustainable, reliable access to their reproductive health technologies.

Women are frequently faced with the challenge of unaffordable reproductive technologies that prevent them from obtaining the healthcare procedures and products they would otherwise choose.  Globally, women may not have access to products because of their inability to pay for a high priced pharmaceutical product or device when they are most in need.

WomanCare Global makes products more affordable through significant discounts in all countries for the public sector and price ceilings in the private sector.  Oftentimes our product offerings are 50 to 70 percent less expensive than large commercial pharmaceutical or medical device competitors.  These reductions create affordable products for women who currently have no options.